Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DTC survey

Executive Summary

FDA plans to survey physicians on direct-to-consumer advertising as follow-up to its 1999 consumer survey (1"The Pink Sheet" Jan. 24, 2000, p. 11). The agency will also conduct a follow-up survey of 775 patients. The physician portion of the study will investigate "DTC-related patient interactions, perceived patient outcomes, attitudes toward appropriate DTC categories, and general opinions about DTC advertising," FDA said
Advertisement

Related Content

FDA's DTC Advertising Survey Should Ask Cost, Insurance Questions - FTC
FDA's DTC Advertising Survey Should Ask Cost, Insurance Questions - FTC
DTC Ads Are "Most Accurate" Rx Info Source Due To FDA Oversight - PhRMA
DTC Ads Are "Most Accurate" Rx Info Source Due To FDA Oversight - PhRMA
One-Third Of Consumers Ignore DTC Print Ad Brief Summary - FDA Survey
One-Third Of Consumers Ignore DTC Print Ad Brief Summary - FDA Survey
Advertisement
UsernamePublicRestriction

Register

PS037507

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel